Long-Term PACE Follow-Up Confirms Ponatinib’s Benefit in CP-CML
At five-year follow-up, treatment with the third-generation tyrosine kinase inhibitor (TKI) ponatinib led to deep and durable responses in patients with heavily pretreated chronic-phase...
FDA Approves Nilotinib for Frontline and Secondline Use in Pediatric CML
The FDA approved nilotinib for first- and secondline use in pediatric patients (≥1 year) with Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukemia (CP-CML).
Approval was...
National Academy of Medicine Launches Resource Center Addressing Physician Burnout
The National Academy of Medicine (NAM) launched the Clinician Well-Being Knowledge Hub, a comprehensive repository housing resources to combat physician burnout. The Knowledge Hub...
CMS Decides Coverage Requirements for NGS-Based Testing
CMS released a National Coverage Determination (NCD) on next-generation sequencing (NGS) for Medicare beneficiaries with advanced cancer. The agency determined that NGS as a...
Ivosidenib Receives Priority Review for the Treatment of Relapsed/Refractory AML
The FDA granted priority review to ivosidenib for the treatment of relapsed/refractory IDH1-mutated AML. The decision was based on results from an ongoing, single-arm,...
FDA Expands Treatment Window for Blood Clot Retrieval Device
The FDA cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset –...
Report: U.S. Health-Care Spending Projections Increase Year Over Year
A new report from the U.S. Centers for Medicare and Medicaid Services (CMS) projects that health-care spending will increase 5.3 percent in 2018 –...
NIH Funding Tied to FDA Approval of 210 Drugs Since 2010
A report published in Proceedings of the National Academy of Sciences found that funding from the National Institutes of Health (NIH) contributed to published...
ASCO Updates Platelet Transfusion Guidelines for Patients With Cancer
ASCO Updates Platelet Transfusion Guidelines for Patients With Cancer
Adult patients undergoing hematopoietic cell transplantation (HCT) can safely delay platelet transfusion until the first sign...
Stand Up To Cancer Funds AI Research, Damon Runyon Cancer Research Foundation Research Fellows...
Remembering Barry Paw (1961-2017)
Barry Paw, MD, PhD, a principal investigator and pediatric oncologist at Brigham and Women’s Hospital and Dana-Farber/Boston Children’s Cancer and Blood...
Current Issue
April 2018, Volume 4, Issue 5
This issue features a look at the U.S. health-care system’s transition from a paper-based system to electronic health records, an introduction to a series about oncology nurse practitioners, and more.
